# Combination of EGFR-TKIs with chemotherapy versus chemotherapy or EGFR-TKIs alone in advanced NSCLC patients with EGFR mutation

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/combination-of-egfr-tkis-with-chemotherapy-versus-chemotherapy-or-egfr-tkis/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Miaomiao Wen,Jinghua Xia,Ying Sun,Xuejiao Wang,Xianghui Fu,Yanning Zhang,Zhipei Zhang,Yongan Zhou,Xiaofei Li |
| Citations | 23 |
| DOI | 10.2147/btt.s169305 |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://www.dovepress.com/getfile.php?fileID=46668 |
| OpenAlex ID | https://openalex.org/W2902633342 |
| PMID | 30555222 |
| Type | article |
| Year | 2018 |

## Paper authors

- [Xuejiao Wang](https://scholariq.org/researchers/xuejiao-wang/)

## Paper journal

- [Biologics](https://scholariq.org/journals/biologics/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.